And right now we are 2 minutes away from the end of the trading day. Romaine Bostick here with Katie Greifeld taking you through to that closing bell with the global simulcast. There's Carol Massar, Tim Stenovec in the radio booth.Welcome to our audiences across all of our Bloomberg platforms, including our partnership with YouTube kicking off the month of December. Carol On a bit of a down note. Yeah, I mean, it's kind of just I feel like malaise in the equity markets.What's really captured my attention, t ...

Contact Us Back to the Newsroom Zimtu Capital Corp. Announces Closing of Warrant Exercise Incentive Program Monday, 01 December 2025 05:50 PM Topic:Â Company Update VANCOUVER, BC / ACCESS Newswire / December 1, 2025 / Zimtu Capital Corp. (TSXV:ZC)(FSE:ZCT1) (the "Company" or "Zimtu") is pleased to announce that, further to its news release dated October 24, 2025, the Company has completed its warrant exercise incentive program (the "Incentive Program") by issuing an aggregate 4,359,687 incentive warrants (t ...

According to the latest 13F filings, several major institutional investors increased their holdings in Visa Inc. (V), signaling broad confidence in the company’s dominant payment network, strong free cash flow generation, and durable long-term growth. Here are the most significant additions from the quarter:TCI Fund Management LTD (Chris Hohn)Shares: 28,057,351  Change: +8,989,793  Value: $9.58BChris Hohn made the largest purchase, from our list, this quarter, adding nearly 9 million shares. The aggressive ...

SAN DIEGO, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP announces that a class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Skye Bioscience, Inc. (NASDAQ: SKYE) securities between November 4, 2024 and October 3, 2025, inclusive (the “Class Period”). The lawsuit seeks to recover losses for investors under the federal securities laws. What if I purchased Skye Bioscience securities?If you purchased Skye Bioscience securities during the Class Period and suff ...

Bala Cynwyd, Pennsylvania--(Newsfile Corp. - December 1, 2025) - Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of Cadence Bank ("Cadence Bank" or the "Company") (NYSE: CADE) for possible breaches of fiduciary duty and other violations of federal and state law in connection with the sale of the Company to Huntington Bancshares Incorporated (Nasdaq - HBAN) in an all-stock deal valued at $7.4 billion. Under the terms of the agreement, Huntingt ...

Bitcoin and companies tied to cryptocurrencies extended a nearly two-month swoon Monday, tracking with a broader market sell-off in technology companies that many see as overvalued.Bitcoin slid 5.6% after being down nearly 12% earlier in the day, settling in just above $85,000. The most-traded cryptocurrency is down about 33% since hitting a record $126,210.50 on Oct. 6, according to crypto trading platform Coinbase. Bitcoin had soared since April in line with the stock market and driven partly by a more cr ...

(Bloomberg) -- Iren Ltd., a data center firm focused on artificial intelligence and high-performance computing, is seeking to raise $2 billion across two convertible bond issues.The company is offering $1 billion of notes due 2032 and a further $1 billion due 2033, according to a statement Monday. The 6.5-year tranche is being marketed with a 0% to 0.25% coupon, while the 7.5 year issue has a 0.5% to 1% coupon, according to people familiar with the matter.The Sydney-based firm is one of several so-called ne ...

ROSEN, NATIONAL TRIAL COUNSEL, Encourages Tandem Diabetes Care, Inc. Investors with Losses in Excess of $100K to Inquire About Securities Class Action Investigation - TNDMDecember 01, 2025 5:46 PM EST | Source: The Rosen Law Firm PANew York, New York--(Newsfile Corp. - December 1, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) resulting from allegations t ...

Share Mountain Valley MD Confirms Positive Agrarius Agricultural Trial Results, Advancing Toward Commercialization MVMD has been working with a client-directed third-party agricultural partner, FARMATAC, in Brazil to assess the impact of the application of the Agrarius product on mature citrus orchards. FARMATAC has extensive experience designing and managing advanced citrus trials and has completed evaluations on two key varieties of oranges in mature orchards: Hamlin and Valencia. TORONTO--(BUSINESS WIRE) ...

Shoppers spent $17.3 billion online on Cyber Monday, Salesforce data showed, capping the Black Friday weekend. ...